ReviewInternational journal of molecular sciences2021

Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.

Erin R Scheidemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.